Education
Academic Background-
Ph.D. Duke University Medical Center, USA Pharmacology and Experimental Oncology | Completed: 1995
Publications (56)
Selected Scholarly Contributions
Endothelin System Blockade Extenuates Sepsis‐Induced Acute Heart and Kidney Injuries via Modulating ET‐1/Klotho/p38‐MAPK
2025
Astaxanthin extenuates the inhibition of aldehyde dehydrogenase and Klotho protein expression in cyclophosphamide‐induced acute cardiomyopathic rat model
2022
Potential role of oxidative stress on the prescription of rehabilitation interventions in spinal cord injury.
Mohamed Mohamed Sayed-Ahmed
2013
Novel 4(3H)-quinazolinone analogs: Synthesis and anticonvulsant activity.
Mohamed Mohamed Sayed-Ahmed
2013
Increased expression of biological markers as potential therapeutic targets in Saudi women with triple-negative breast cancer.
Mohamed Mohamed Sayed-Ahmed
2012
MicroRNAs and metastasis-related gene expression in egyptian breast cancer patients.
Mohamed Mohamed Sayed-Ahmed
2012
Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2-a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6]diazepine analogues.
Mohamed Mohamed Sayed-Ahmed
2011
Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Mohamed Mohamed Sayed-Ahmed
2011
L-carnitine attenuates ifosfamide-induced carnitine deficiency and decreased intramitochondrial CoA-SH in rat kidney tissues.
Mohamed Mohamed Sayed-Ahmed
2011
Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats.
Mohamed Mohamed Sayed-Ahmed
2011
Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: Molecular docking study.
Mohamed Mohamed Sayed-Ahmed
2010
Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation.
Mohamed Mohamed Sayed-Ahmed
2010
Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model.
Mohamed Mohamed Sayed-Ahmed
2010
Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signaling.
Mohamed Mohamed Sayed-Ahmed
2010
Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.
Mohamed Mohamed Sayed-Ahmed
2010
Progression of cyclophosphamide-induced acute renal metabolic damage in carnitine-depleted rat model.
Mohamed Mohamed Sayed-Ahmed
2010
Nitric oxide pros and cons: The role of L-arginine, a nitric oxide precursor and idebenone, a coenzyme-Q analogue in ameliorating cerebral hypoxia in rat.
Mohamed Mohamed Sayed-Ahmed
2010
Thymoquinone supplementation reverses acetaminophen-induced oxidative stress, nitric oxide production and energy decline in mice liver.
Mohamed Mohamed Sayed-Ahmed
2010
Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model.
Mohamed Mohamed Sayed-Ahmed
2010
Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats.
Mohamed Mohamed Sayed-Ahmed
2010
Increased urinary losses of carnitine and decreased intramitochondrial coenzyme a in gentamicin-induced acute renal failure in rats.
Mohamed Mohamed Sayed-Ahmed
2010
Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats.
Mohamed Mohamed Sayed-Ahmed
2009
Reversal of doxorubicin resistance by adenovirus-mediated transfer of cyclooxygenase-2 antisense in multidrug-resistant MCF-7 cells.
Mohamed Mohamed Sayed-Ahmed
2007
Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Mohamed Mohamed Sayed-Ahmed
2007
Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats.
Mohamed Mohamed Sayed-Ahmed
2007
Multidrug resistance to cancer chemotherapy: Genes involved and blockers.
Mohamed Mohamed Sayed-Ahmed
2007
Increased serum and cardiac acyl-carnitine/free carnitine ratio during development of doxorubicin-induced cardiotoxicity.
Mohamed Mohamed Sayed-Ahmed
2007
Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus.
Mohamed Mohamed Sayed-Ahmed
2006
Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model.
Mohamed Mohamed Sayed-Ahmed
2006
Contribution of nitric oxide and epidermal growth factor receptor in antimetastatic potenial of paclitaxel in human liver cancer cells (Heb G2).
Mohamed Mohamed Sayed-Ahmed
2005
Probucol attenuates oxidative stress and energy decline in isoproterenol-induced heart failure in rat.
Mohamed Mohamed Sayed-Ahmed
2005
Acetyl-L-carnitine modulates bleomycin-induced oxidative stress and energy depletion in lung tissues.
Mohamed Mohamed Sayed-Ahmed
2004
Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.
Mohamed Mohamed Sayed-Ahmed
2004
Protective role of carnitine esters against Alcohol-induced gastric lesions in rats.
Mohamed Mohamed Sayed-Ahmed
2003
New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
Mohamed Mohamed Sayed-Ahmed
2003
Contribution of nitric oxide in doxorubicin-related cytotoxicity in murine tumour model.
Mohamed Mohamed Sayed-Ahmed
2002
L-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits.
Mohamed Mohamed Sayed-Ahmed
2001
Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy.
Mohamed Mohamed Sayed-Ahmed
2001
Modulation of radiation-induced organs toxicity by cremophor-el in experimental animals.
Mohamed Mohamed Sayed-Ahmed
2001
Propionyl-l-carnitine as protector against adriamycin-induced cardiomyopathy.
Mohamed Mohamed Sayed-Ahmed
2001
Effect of cremophor-El on cisplatin induced organs toxicity in normal rats.
Mohamed Mohamed Sayed-Ahmed
2001
Plasma endothelin (ET-1) as a marker for doxorubicin-induced cardiotoxicity in egyptian patients.
Mohamed Mohamed Sayed-Ahmed
2000
Modulation by verapamil of doxorubicin induced expression of multidrug resistance gene (mdr-1/P-glycoprotein) in murine tumour cells.
Mohamed Mohamed Sayed-Ahmed
2000
Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid β-oxidation in isolated heart mitochondria.
Mohamed Mohamed Sayed-Ahmed
2000
Protection by L-carnitine against the inhibition of gene expression of heart fatty acid binding protein by chronic administration of doxorubicin.
Mohamed Mohamed Sayed-Ahmed
2000
Effects of trichloroactate, water chlorination by-product, on liver peroxisomes and antioxidant status in rats and mice.
Mohamed Mohamed Sayed-Ahmed
2000
The protective effect of methimazole against cisplatin-induced chromosomal abberrations.
Mohamed Mohamed Sayed-Ahmed
1999
Reversal of doxorubicin-induced cardiac metabolic damage by l-carnitine.
Mohamed Mohamed Sayed-Ahmed
1999
Potenial promise of using L-carnitine and Coenzyme Q10 as protective agents against Cisplatin-induced nephrotoxicity.
Mohamed Mohamed Sayed-Ahmed
1999
Verapamil enhancement of the cytotoxic and cell cycle perturbation of doxorubicin in Ehrlich ascites carcinoma cells in vivo.
Mohamed Mohamed Sayed-Ahmed
1999
Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes.
Mohamed Mohamed Sayed-Ahmed
1997
Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes.
Mohamed Mohamed Sayed-Ahmed
1996
Stimulation of non-oxidative glucose utilization by L-carnitine in isolated myocytes.
Mohamed Mohamed Sayed-Ahmed
1995
Reduced induction of carbohydrate utilization by inhibition of fatty acid oxidation in myocytes from diabetic animals.
Mohamed Mohamed Sayed-Ahmed
1994
Potentiation of the chemotherapeutic effect of methotrexate by hyperthermia in experimental animal tumour model.
Mohamed Mohamed Sayed-Ahmed
1994
Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma.
Mohamed Mohamed Sayed-Ahmed
1993